Home
Live Updates
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript : comparemela.com
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.07464, expectations were $-0.17.
Related Keywords
Japan ,
Canada ,
Florida ,
United States ,
Switzerland ,
Canadian ,
Japanese ,
Swiss ,
Farzin Haque ,
Greg Keenan ,
Stacy Ku ,
Andrea Christopher ,
Joe Miller ,
Peter Greenleaf ,
Maury Raycroft ,
Investor Relations For Aurinia Pharmaceuticals ,
Exchange Commission ,
Nasdaq ,
Aurinia Pharmaceuticals First Quarter ,
Head Of Corporate Communications ,
Aurinia Pharmaceuticals Inc ,
Aurinia Pharmaceuticals ,
Call Transcript May ,
Corporate Communications ,
Investor Relations ,
Chief Executive Officer ,
Chief Financial Officer ,
Chief Medical ,
Lupus Awareness ,
Highest Rates ,
Stomach Cancer ,
Cheapest Cities To Retire ,
comparemela.com © 2020. All Rights Reserved.